Apimeds Pharmaceuticals appoints Eric Sherb as CFO effective Oct. 1

• Apimeds Pharmaceuticals US named Eric Sherb as chief financial officer effective Oct. 1, 2026.
• Interim CFO Erick Frim resigned effective immediately on Sept. 29, 2026.
• Sherb, a CPA, founded EMS Consulting Services in 2019, providing CFO services, SEC reporting, PCAOB audit coordination, M&A support.
• He previously served as fractional CFO of MindWave Innovations, a wholly owned subsidiary, since February 2026; that engagement will end.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals US Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-105484), on October 01, 2026, and is solely responsible for the information contained therein.